{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:36:31Z","timestamp":1793086591513,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>The COVID-19 pandemic impacted the operationalisation of non-COVID-19 clinical trials globally, particularly site and participant recruitment and trial success\/stoppage. Trials which anticipate recruitment challenges may embed methods such as the QuinteT Recruitment Intervention (QRI) to help identify and understand the sources of challenges. Such interventions can help shed light on pandemic-related challenges. This paper reports our experience of the impact of the COVID-19 pandemic on conducting clinical trials with an embedded QRI, highlighting how the QRI aided in identifying challenges and potential solutions, particularly related to the site set-up and participant recruitment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>We report on 13 UK clinical trials which included a QRI. Information is from QRI data and researchers\u2019 experience and reflections. In most trials, recruitment was lower than even the lowest anticipated rates. The flexibility of the QRI facilitated rapid data collection to understand and document, and in some instances respond to, operational challenges. Challenges were mostly logistical, pandemic-related and beyond the control of the site or central trial teams. Specifically: disrupted and variable site opening timelines \u2014often due to local research and development (R&amp;D) delays\u2014 shortages of staff to recruit patients; fewer eligible patients or limited access to patients; and intervention-related factors. Almost all trials were affected by pandemic-related staffing issues including redeployment, prioritisation of COVID-19 care and research, and COVID-19-related staff illness and absence. Trials of elective procedures were particularly impacted by the pandemic, which caused changes to care\/recruitment pathways, deprioritisation of services, reduced clinical and surgical capacity and longer waiting lists. Attempted solutions included extra engagement with staff and R&amp;D departments, trial protocol changes (primarily moving online) and seeking additional resourcing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We have highlighted wide-ranging, extensive and consistent pandemic-related challenges faced by UK clinical trials, which the QRI helped to identify and, in some cases, address. Many challenges were insurmountable at individual trials or trials unit level. This overview highlights the need to streamline trial regulatory processes, address staffing crises, improve recognition of NHS research staff and for clearer, more nuanced central guidance on the prioritisation of studies and how to deal with the backlog. Pre-emptively embedding qualitative work and stakeholder consultation into trials with anticipated difficulties, moving some processes online, and flexible trial protocols may improve the resilience of trials in the current challenging context.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07414-w","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T09:15:18Z","timestamp":1687425318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3254-004X","authenticated-orcid":false,"given":"Ava","family":"Lorenc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Rooshenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Conefrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeetha","family":"Paramasivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Realpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Jepson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"issue":"8","key":"7414_CR1","doi-asserted-by":"publisher","first-page":"e0256871","DOI":"10.1371\/journal.pone.0256871","volume":"16","author":"D Wyatt","year":"2021","unstructured":"Wyatt D, Faulkner-Gurstein R, Cowan H, Wolfe CDA. Impacts of COVID-19 on clinical research in the UK: a multi-method qualitative case study. PLoS ONE. 2021;16(8):e0256871.","journal-title":"PLoS ONE"},{"issue":"1","key":"7414_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13063-021-05219-3","volume":"22","author":"JM Unger","year":"2021","unstructured":"Unger JM, Xiao H. The COVID-19 pandemic and new clinical trial activations. Trials. 2021;22(1):260.","journal-title":"Trials"},{"issue":"1","key":"7414_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcdd9010019","volume":"9","author":"K Audisio","year":"2022","unstructured":"Audisio K, Lia H, Robinson NB, Rahouma M, Soletti G, Cancelli G, et al. Impact of the COVID-19 pandemic on non-COVID-19 clinical trials. J Cardiovasc Dev Dis. 2022;9(1):19.","journal-title":"J Cardiovasc Dev Dis"},{"key":"7414_CR4","unstructured":"Medidata Solutions Inc. COVID-19 and clinical trials: the Medidata perspective. Release 9.0 2020. Available from: https:\/\/www.medidata.com\/wp-content\/uploads\/2020\/09\/COVID19-Response9.0_Clinical-Trials_2020921_v2.pdf. Accessed: 12\/05\/22."},{"key":"7414_CR5","unstructured":"Hillman A. COVID-19: explaining the UK\u2019s slow recovery in clinical trial activity 2022 [31\/01\/2022]. Available from: https:\/\/www.clinicaltrialsarena.com\/analysis\/uk-clinical-trials-covid-19-2\/. Accessed:"},{"issue":"1","key":"7414_CR6","doi-asserted-by":"publisher","first-page":"e2036353-e","DOI":"10.1001\/jamanetworkopen.2020.36353","volume":"4","author":"EB Lamont","year":"2021","unstructured":"Lamont EB, Diamond SS, Katriel RG, Ensign LL, Liu J, Rusli E, et al. Trends in oncology clinical trials launched before and during the COVID-19 pandemic. JAMA Netw Open. 2021;4(1):e2036353-e.","journal-title":"JAMA Netw Open."},{"issue":"6","key":"7414_CR7","doi-asserted-by":"publisher","first-page":"e2010651-e","DOI":"10.1001\/jamanetworkopen.2020.10651","volume":"3","author":"JM Unger","year":"2020","unstructured":"Unger JM, Blanke CD, LeBlanc M, Hershman DL. Association of the coronavirus disease 2019 (COVID-19) outbreak with enrollment in cancer clinical trials. JAMA Network Open. 2020;3(6):e2010651-e.","journal-title":"JAMA Network Open."},{"issue":"7867","key":"7414_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/d41586-021-01569-9","volume":"595","author":"H Ledford","year":"2021","unstructured":"Ledford H. The COVID pandemic\u2019s lingering impact on clinical trials. Nature. 2021;595(7867):341\u20132.","journal-title":"Nature"},{"issue":"5","key":"7414_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1177\/1049732319828693","volume":"29","author":"L Rooshenas","year":"2019","unstructured":"Rooshenas L, Paramasivan S, Jepson M, Donovan JL. Intensive triangulation of qualitative research and quantitative data to improve recruitment to randomized trials: the QuinteT approach. Qual Health Res. 2019;29(5):672\u20139.","journal-title":"Qual Health Res"},{"key":"7414_CR10","unstructured":"University of Bristol. QuinteT Recruitment Intervention 2022. Available from: https:\/\/www.bristol.ac.uk\/population-health-sciences\/research\/groups\/social-sciences-health\/quintet\/interventions\/. Accessed:"},{"issue":"8","key":"7414_CR11","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jclinepi.2014.03.010","volume":"67","author":"JL Donovan","year":"2014","unstructured":"Donovan JL, de Salis I, Toerien M, Paramasivan S, Hamdy FC, Blazeby JM. The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomized controlled trials. J Clin Epidemiol. 2014;67(8):912\u201320.","journal-title":"J Clin Epidemiol"},{"key":"7414_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-6215-15-5","volume":"15","author":"JL Donovan","year":"2014","unstructured":"Donovan JL, Paramasivan S, de Salis I, Toerien M. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials. 2014;15:5.","journal-title":"Trials"},{"issue":"6","key":"7414_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bju.14432","volume":"122","author":"D Elliott","year":"2018","unstructured":"Elliott D, Hamdy FC, Leslie TA, Rosario D, Dudderidge T, Hindley R, et al. Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer. BJU Int. 2018;122(6):970\u20137.","journal-title":"BJU Int"},{"issue":"1","key":"7414_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1186\/s13063-022-06818-4","volume":"23","author":"N Farrar","year":"2022","unstructured":"Farrar N, Elliott D, Houghton C, Jepson M, Mills N, Paramasivan S, et al. Understanding the perspectives of recruiters is key to improving randomised controlled trial enrolment: a qualitative evidence synthesis. Trials. 2022;23(1):883.","journal-title":"Trials"},{"key":"7414_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jclinepi.2018.02.018","volume":"99","author":"M Jepson","year":"2018","unstructured":"Jepson M, Elliott D, Conefrey C, Wade J, Rooshenas L, Wilson C, et al. An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment. J Clin Epidemiol. 2018;99:75\u201383.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"7414_CR16","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/ijo.2017.153","volume":"41","author":"S Paramasivan","year":"2017","unstructured":"Paramasivan S, Rogers CA, Welbourn R, Byrne JP, Salter N, Mahon D, et al. Enabling recruitment success in bariatric surgical trials: pilot phase of the By-Band-Sleeve study. Int J Obes (Lond). 2017;41(11):1654\u201361.","journal-title":"Int J Obes (Lond)"},{"key":"7414_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jclinepi.2016.02.002","volume":"76","author":"A Realpe","year":"2016","unstructured":"Realpe A, Adams A, Wall P, Griffin D, Donovan JL. A new simple six-step model to promote recruitment to RCTs was developed and successfully implemented. J Clin Epidemiol. 2016;76:166\u201374.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"7414_CR18","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.socscimed.2009.02.023","volume":"68","author":"J Wade","year":"2009","unstructured":"Wade J, Donovan JL, Athene Lane J, Neal DE, Hamdy FC. It\u2019s not just what you say, it\u2019s also how you say it: opening the \u2018black box\u2019 of informed consent appointments in randomised controlled trials. Soc Sci Med. 2009;68(11):2018\u201328.","journal-title":"Soc Sci Med"},{"issue":"6","key":"7414_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1258\/jrsm.2008.070373","volume":"101","author":"A Hackshaw","year":"2008","unstructured":"Hackshaw A, Farrant H, Bulley S, Seckl MJ, Ledermann JA. Setting up non-commercial clinical trials takes too long in the UK: findings from a prospective study. J R Soc Med. 2008;101(6):299\u2013304.","journal-title":"J R Soc Med"},{"issue":"9","key":"7414_CR20","doi-asserted-by":"publisher","first-page":"e005874","DOI":"10.1136\/bmjopen-2014-005874","volume":"4","author":"A Kearney","year":"2014","unstructured":"Kearney A, McKay A, Hickey H, Balabanova S, Marson AG, Gamble C, et al. Opening research sites in multicentre clinical trials within the UK: a detailed analysis of delays. BMJ Open. 2014;4(9):e005874.","journal-title":"BMJ Open"},{"issue":"1","key":"7414_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s13063-020-04798-x","volume":"21","author":"R Greenwood","year":"2020","unstructured":"Greenwood R, Pell J, Foscarini-Craggs P, Wale K, Thomas I, Bradbury C. Letter on Predicting the number of sites needed to deliver a multicentre clinical trial within a limited time frame in the UK. Trials. 2020;21(1):873.","journal-title":"Trials"},{"key":"7414_CR22","volume-title":"Urgent action to address the current research delivery challenges in the NHS","author":"L Chappell","year":"2022","unstructured":"Chappell L, Wood L. Urgent action to address the current research delivery challenges in the NHS. 2022."},{"key":"7414_CR23","unstructured":"DHSC, NHS England. Research reset: case for change 2022. Available from: https:\/\/sites.google.com\/nihr.ac.uk\/thefutureofukclinicalresearch\/home\/research-reset\/research-reset-case-for-change?authuser=0. Accessed: 15\/09\/22."},{"key":"7414_CR24","volume-title":"12 actions to support and apply research in the NHS","author":"NHS England","year":"2017","unstructured":"NHS England. 12 actions to support and apply research in the NHS. 2017."},{"key":"7414_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.puhe.2017.12.022","volume":"157","author":"L Jonker","year":"2018","unstructured":"Jonker L, Fisher SJ. The correlation between National Health Service trusts\u2019 clinical trial activity and both mortality rates and care quality commission ratings: a retrospective cross-sectional study. Public Health. 2018;157:1\u20136.","journal-title":"Public Health"},{"issue":"1","key":"7414_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/jep.13118","volume":"26","author":"L Jonker","year":"2020","unstructured":"Jonker L, Fisher SJ, Dagnan D. Patients admitted to more research-active hospitals have more confidence in staff and are better informed about their condition and medication: results from a retrospective cross-sectional study. J Eval Clin Pract. 2020;26(1):203\u20138.","journal-title":"J Eval Clin Pract"},{"key":"7414_CR27","volume-title":"Socio-economic inequalities in access to planned hospital care: causes and consequences","author":"The Strategy Unit","year":"2021","unstructured":"The Strategy Unit. Socio-economic inequalities in access to planned hospital care: causes and consequences. 2021."},{"key":"7414_CR28","doi-asserted-by":"publisher","first-page":"o3","DOI":"10.1136\/bmj.o3","volume":"376","author":"G Iacobucci","year":"2022","unstructured":"Iacobucci G. COVID-19: NHS trusts declare \u201ccritical incidents\u201d because of staff shortages. BMJ. 2022;376:o3.","journal-title":"BMJ"},{"issue":"2","key":"7414_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.surg.2020.09.012","volume":"169","author":"SG Keswani","year":"2021","unstructured":"Keswani SG, Parikh UM, Gosain A, Ghaferi AA, Thomas JS, Dudeja V, et al. Impact of the coronavirus disease 2019 pandemic on surgical research and lessons for the future. Surgery. 2021;169(2):257\u201363.","journal-title":"Surgery"},{"issue":"1","key":"7414_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s13063-022-06315-8","volume":"23","author":"EJ Mitchell","year":"2022","unstructured":"Mitchell EJ, Goodman K, Wakefield N, Cochran C, Cockayne S, Connolly S, et al. Clinical trial management: a profession in crisis? Trials. 2022;23(1):357.","journal-title":"Trials"},{"issue":"16_suppl","key":"7414_CR31","doi-asserted-by":"publisher","first-page":"11049","DOI":"10.1200\/JCO.2022.40.16_suppl.11049","volume":"40","author":"DS Dizon","year":"2022","unstructured":"Dizon DS, Szczepanek CM, Petrylak DP, Sparks DB, Tangen C, Lara PLN, et al. National impact of the COVID-19 pandemic on clinical trial staff attrition: results of the SWOG Cancer Research Network Survey of Oncology Research Professionals. J Clin Oncol. 2022;40(16_suppl):11049.","journal-title":"J Clin Oncol."},{"issue":"4","key":"7414_CR32","doi-asserted-by":"publisher","first-page":"030006052210931","DOI":"10.1177\/03000605221093179","volume":"50","author":"A Bauer","year":"2022","unstructured":"Bauer A, Eskat A, Ntekim A, Wong C, Eberle D, Hedayati E, et al. How COVID-19 changed clinical research strategies: a global survey. J Int Med Res. 2022;50(4):03000605221093179.","journal-title":"J Int Med Res"},{"issue":"2","key":"7414_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/1475-5890.12227","volume":"41","author":"C Propper","year":"2020","unstructured":"Propper C, Stoye G, Zaranko B. The wider impacts of the coronavirus pandemic on the NHS*. Fisc Stud. 2020;41(2):345\u201356.","journal-title":"Fisc Stud"},{"issue":"1","key":"7414_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/jamaoncol.2020.5748","volume":"7","author":"ME Fleury","year":"2021","unstructured":"Fleury ME, Farner AM, Unger JM. Association of the COVID-19 outbreak with patient willingness to enroll in cancer clinical trials. JAMA Oncol. 2021;7(1):131\u20132.","journal-title":"JAMA Oncol"},{"issue":"1","key":"7414_CR35","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1186\/s13063-020-04711-6","volume":"21","author":"EJ Mitchell","year":"2020","unstructured":"Mitchell EJ, Ahmed K, Breeman S, Cotton S, Constable L, Ferry G, et al. It is unprecedented: trial management during the COVID-19 pandemic and beyond. Trials. 2020;21(1):784.","journal-title":"Trials"},{"key":"7414_CR36","doi-asserted-by":"publisher","unstructured":"Ghoreifi A, Sobhani S, Moghaddam FS, Djaladat H. The challenges of urological research in COVID-19 era: lessons learned for immediate response to the pandemic. Urology.\u00a0165:13\u201317. https:\/\/doi.org\/10.1016\/j.urology.2022.04.006.","DOI":"10.1016\/j.urology.2022.04.006"},{"issue":"1","key":"7414_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13063-016-1391-4","volume":"17","author":"JL Donovan","year":"2016","unstructured":"Donovan JL, Rooshenas L, Jepson M, Elliott D, Wade J, Avery K, et al. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI). Trials. 2016;17(1):283.","journal-title":"Trials"},{"issue":"1","key":"7414_CR38","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s13063-022-06385-8","volume":"23","author":"EC O\u2019Brien","year":"2022","unstructured":"O\u2019Brien EC, Sugarman J, Weinfurt KP, Larson EB, Heagerty PJ, Hernandez AF, et al. The impact of COVID-19 on pragmatic clinical trials: lessons learned from the NIH Health Care Systems Research Collaboratory. Trials. 2022;23(1):424.","journal-title":"Trials"},{"issue":"7","key":"7414_CR39","doi-asserted-by":"publisher","first-page":"332-.e1","DOI":"10.5694\/mja2.50991","volume":"214","author":"A Sarah","year":"2021","unstructured":"Sarah A, Dean O, Berk M. The evolution of clinical trials in response to COVID-19. Med J Aust. 2021;214(7):332-.e1.","journal-title":"Med J Aust."},{"issue":"7","key":"7414_CR40","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/imj.14339","volume":"49","author":"H Lunt","year":"2019","unstructured":"Lunt H, Connor S, Skinner H, Brogden G. Electronic informed consent: the need to redesign the consent process for the digital age. Intern Med J. 2019;49(7):923\u20139.","journal-title":"Intern Med J"},{"issue":"11","key":"7414_CR41","doi-asserted-by":"publisher","first-page":"e22179","DOI":"10.2196\/22179","volume":"22","author":"M Br\u00f8gger-Mikkelsen","year":"2020","unstructured":"Br\u00f8gger-Mikkelsen M, Ali Z, Zibert JR, Andersen AD, Thomsen SF. Online patient recruitment in clinical trials: systematic review and meta-analysis. J Med Internet Res. 2020;22(11):e22179.","journal-title":"J Med Internet Res"},{"key":"7414_CR42","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4018\/978-1-7998-8490-3.ch017","volume-title":"Contemporary issues in global medicine and moving toward international healthcare equity","author":"RR Johnson","year":"2022","unstructured":"Johnson RR, D\u2019Abundo ML. Improving clinical trial diversity: the impending role of technology-oriented strategies amid the COVID-19 pandemic. In: Comninellis N, Waldman SD, editors. Contemporary issues in global medicine and moving toward international healthcare equity. Hershey, PA, USA: IGI Global; 2022. p. 348\u201377."},{"issue":"1","key":"7414_CR43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12874-022-01609-6","volume":"22","author":"R Chatters","year":"2022","unstructured":"Chatters R, Cooper CL, O\u2019Cathain A, Murphy C, Lane A, Sutherland K, et al. Learning from COVID-19 related trial adaptations to inform efficient trial design\u2014a sequential mixed methods study. BMC Med Res Methodol. 2022;22(1):128.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"7414_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s13063-022-06333-6","volume":"23","author":"R Almeida-Magana","year":"2022","unstructured":"Almeida-Magana R, Maroof H, Grierson J, Clow R, Dinneen E, Al-Hammouri T, et al. E-consent\u2014a guide to maintain recruitment in clinical trials during the COVID-19 pandemic. Trials. 2022;23(1):388.","journal-title":"Trials"},{"key":"7414_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jclinepi.2018.04.011","volume":"100","author":"L Jefferson","year":"2018","unstructured":"Jefferson L, Fairhurst C, Brealey S, Coleman E, Cook L, Hewitt C, et al. Remote or on-site visits were feasible for the initial setup meetings with hospitals in a multicenter surgical trial: an embedded randomized trial. J Clin Epidemiol. 2018;100:13\u201321.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"7414_CR46","doi-asserted-by":"publisher","first-page":"e30055","DOI":"10.2196\/30055","volume":"6","author":"K Tiersma","year":"2022","unstructured":"Tiersma K, Reichman M, Popok PJ, Nelson Z, Barry M, Elwy AR, et al. The strategies for quantitative and qualitative remote data collection: lessons from the COVID-19 pandemic. JMIR Form Res. 2022;6(4):e30055.","journal-title":"JMIR Form Res"},{"issue":"1","key":"7414_CR47","first-page":"101","volume":"3","author":"OT Inan","year":"2020","unstructured":"Inan OT, Tenaerts P, Prindiville SA, Reynolds HR, Dizon DS, Cooper-Arnold K, et al. Digitizing clinical trials npj. Digital Med. 2020;3(1):101.","journal-title":"Digital Med"},{"key":"7414_CR48","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.conctc.2022.100973","volume":"29","author":"D Pogorzelski","year":"2022","unstructured":"Pogorzelski D, McKay P, Weaver MJ, Jaeblon T, Hymes RA, Gaski GE, et al. The impact of COVID-19 restrictions on participant enrollment in the PREPARE trial. Contemp Clin Trials Commun. 2022;29:100973.","journal-title":"Contemp Clin Trials Commun"},{"key":"7414_CR49","volume-title":"Physiotherapy for Patients Awaiting Rotator Cuff Repair (POWER)","author":"University Hospitals of Derby and Burton NHS Foundation Trust","year":"2021","unstructured":"University Hospitals of Derby and Burton NHS Foundation Trust. Physiotherapy for Patients Awaiting Rotator Cuff Repair (POWER). 2021."},{"key":"7414_CR50","unstructured":"NIHR. Associate principal investigator (PI) scheme 2022. Available from: https:\/\/www.nihr.ac.uk\/health-and-care-professionals\/career-development\/associate-principal-investigator-scheme.htm. Accessed:"},{"issue":"1","key":"7414_CR51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12910-019-0434-2","volume":"20","author":"SE Kolstoe","year":"2019","unstructured":"Kolstoe SE, Carpenter D. Research approvals iceberg: helping it melt away. BMC Med Ethics. 2019;20(1):100.","journal-title":"BMC Med Ethics"},{"key":"7414_CR52","volume-title":"The importance of a proportionate, risk-based approach to ethics approval: the HRA view","author":"T. A, J. M","year":"2019","unstructured":"T. A, J. M. The importance of a proportionate, risk-based approach to ethics approval: the HRA view. 2019."},{"issue":"6","key":"7414_CR53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1258\/jrsm.2008.080116","volume":"101","author":"T Coats","year":"2008","unstructured":"Coats T, Goodacre S. Time for D in R&D? J R Soc Med. 2008;101(6):268\u20139.","journal-title":"J R Soc Med"},{"issue":"3\u20134","key":"7414_CR54","first-page":"1","volume":"15","author":"V Ranieri","year":"2019","unstructured":"Ranieri V, Stynes H, Kennedy E. Navigating multisite research set-up and approvals: helping researchers on the ground\u2014a commentary. Research Ethics. 2019;15(3\u20134):1\u20135.","journal-title":"Research Ethics"},{"issue":"1","key":"7414_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12910-018-0339-5","volume":"20","author":"M Petrova","year":"2019","unstructured":"Petrova M, Barclay S. Research approvals iceberg: how a \u2018low-key\u2019 study in England needed 89 professionals to approve it and how we can do better. BMC Med Ethics. 2019;20(1):7.","journal-title":"BMC Med Ethics"},{"key":"7414_CR56","doi-asserted-by":"publisher","unstructured":"Peto L, Horby P, Landray M. Establishing COVID-19 trials at scale and pace: experience from the RECOVERY trial. Adv Biol Regul. 2022:100901. https:\/\/doi.org\/10.1016\/j.jbior.2022.100901.","DOI":"10.1016\/j.jbior.2022.100901"},{"key":"7414_CR57","volume-title":"Saving and improving lives: the future of UK clinical research delivery","author":"Department of Health and Social Care","year":"2021","unstructured":"Department of Health and Social Care. Saving and improving lives: the future of UK clinical research delivery. 2021."},{"key":"7414_CR58","doi-asserted-by":"publisher","unstructured":"Airth A, Whittle JR, Dimou J. How has the COVID-19 pandemic impacted clinical care and research in neuro-oncology? J Clin Neurosci. 2022;105:91\u2013102. https:\/\/doi.org\/10.1016\/j.jocn.2022.09.004.","DOI":"10.1016\/j.jocn.2022.09.004"},{"key":"7414_CR59","volume-title":"Urgent action to address the current clinical research delivery challenges in the NHS","author":"NHS","year":"2022","unstructured":"NHS. Urgent action to address the current clinical research delivery challenges in the NHS. 2022."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07414-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07414-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07414-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T10:29:55Z","timestamp":1687429795000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07414-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7414"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07414-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All trials reported in this paper received ethical approval; however, as this paper does not report any data, this is not applicable here.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"424"}}